Register for email alerts and news feeds:
This journal | BMJ Group
To SUBMIT an e-letter please go to the abstract/full text of the article and click the 'Submit a response' link in the box to the right of the text. For further help click here.

* To: ADC Fetal and Neonatal Edition Letters and ADC Education and Practice Letters

Electronic Letters to:

H E Nielsen, E A Andersen, J Andersen, B Böttiger, K M Christiansen, P Daugbjerg, S O Larsen, I Lind, M Nir, and K Olofsson
Diagnostic assessment of haemorrhagic rash and fever
Arch Dis Child 2001; 85: 160-165 [Abstract] [Full text] [PDF]
*eLetters: Submit a response to this article

Electronic letters published:

[Read eLetter] Details on the use of antipyretics?
John M Feller   (13 September 2001)
[Read eLetter] Re: Details on the use of antipyretics?
Hans Erik Nielsen   (20 September 2001)

Details on the use of antipyretics? 13 September 2001
 Next eLetter Top
John M Feller,
Consultant Paediatrician
Sydney Children's Hospital

Send letter to journal:
Re: Details on the use of antipyretics?

johnfeller{at}bigpond.com John M Feller

Dear Editor,

The article by Nielsen et al.(Arch Dis Child Aug 2001), as well as previous articles and letters of many contributors in earlier editions and elsewhere, in considering "diagnosis" in children presenting with purpuric rash(with or without systemic illness), all fail to report on presence or absence of one particular factor. This is details of use of anti- pyretics, other than paracetamol(acetominaphen), in the period preceding onset of rash.

In Australia, where the last two years saw market withdrawal of Paracetamol products after poisoning threats by extortionists, there has been increasing trend towards use of proprietary brands of Ibuprofen, to treat fever. Often the actual systemic symptoms of the causal viral illness may have subsided by the time the purpuric rash of any ensuing side effect of thrombocytopaenia or platelet aggregation dysfunction might manifest. We have had several cases of children, not significantly systemically unwell, presenting this way, where thorough investigation failed to detect any evidence of meningococcal or other bacterial infection, but Ibuprofen had been used in the previous days. Platelet dysfunction is a well-recognised side effect of all COX-1 NSAIDS and enquiry about history of use can be contributory in diagnosis.

Finally, a Gram-stain of blood sampled from a single skin purpuric lesion can be a rapid test for true meningococcemia, and can be a valuable diagnostic test.

Dr. John M. Feller MB BS FRACP
Consultant Paediatrician
Sydney Children's Hospital,
Sydney, AUSTRALIA

Re: Details on the use of antipyretics? 20 September 2001
Previous eLetter  Top
Hans Erik Nielsen,
Consultant
Paediatric Department, Gentofte Hospital, DK

Send letter to journal:
Re: Re: Details on the use of antipyretics?

Hanie{at}gentoftehosp.kbhamt.dk Hans Erik Nielsen

Dear Editor

In response to Dr Feller's comment we can inform you:

That we have not recorded the use of antipyretics.

However, in Denmark, the only drug used for this purpose in children is paracetamol. Ibuprofen and similar NSAIDS are not used. Therefore, a side effect of this group of drugs cannot account for any of the large group of children in whom we found no explanation of the disease.

Yours sincerely

H.E.Nielsen

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs